Piper Sandler Cuts Celsius (NASDAQ:CELH) Price Target to $47.00

Celsius (NASDAQ:CELH) had its price objective trimmed by Piper Sandler from $50.00 to $47.00 in a research note released on Tuesday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities research analysts have also issued reports on CELH. Jefferies Financial Group cut their price target on shares of Celsius from $68.00 to $53.00 and set a buy rating on the stock in a report on Thursday, September 5th. UBS Group cut their target price on Celsius from $70.00 to $64.00 and set a buy rating on the stock in a research note on Wednesday, August 7th. Wedbush lowered their price target on Celsius from $85.00 to $83.00 and set an outperform rating for the company in a research report on Wednesday, June 12th. B. Riley cut their price objective on Celsius from $80.00 to $73.00 and set a buy rating on the stock in a research report on Wednesday, August 7th. Finally, Roth Mkm reduced their target price on Celsius from $65.00 to $45.00 and set a buy rating on the stock in a research note on Thursday, September 5th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of Moderate Buy and a consensus target price of $57.43.

Celsius Trading Up 1.0 %

CELH opened at $31.32 on Tuesday. The company has a market cap of $7.30 billion, a P/E ratio of 34.42, a P/E/G ratio of 2.45 and a beta of 1.85. Celsius has a 12 month low of $30.86 and a 12 month high of $99.62. The business’s 50-day moving average price is $39.17 and its 200-day moving average price is $62.58.

Celsius (NASDAQ:CELH) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.05. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The firm had revenue of $402.00 million during the quarter, compared to the consensus estimate of $391.07 million. During the same quarter in the previous year, the company posted $0.17 earnings per share. The business’s revenue was up 23.4% on a year-over-year basis. Equities research analysts forecast that Celsius will post 0.82 earnings per share for the current fiscal year.

Insider Buying and Selling at Celsius

In other news, CEO John Fieldly sold 74,847 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the sale, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

Several hedge funds have recently added to or reduced their stakes in CELH. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Celsius in the 2nd quarter worth about $695,000. Newbridge Financial Services Group Inc. raised its holdings in Celsius by 3,150.0% in the second quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock worth $37,000 after buying an additional 630 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Celsius in the second quarter worth approximately $2,827,000. Clearbridge Investments LLC purchased a new stake in shares of Celsius during the second quarter valued at approximately $591,000. Finally, Cetera Investment Advisers grew its holdings in shares of Celsius by 189.3% during the second quarter. Cetera Investment Advisers now owns 186,476 shares of the company’s stock valued at $10,646,000 after buying an additional 122,011 shares during the last quarter. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.